• Home
  • Invest with Barry
  • Speaking
  • Contact
  • MiB Podcast

Deal Flurry Shows Drug Makers’ Swing Toward Specialization

April 29, 2014 6:00am by Barry Ritholtz


Source: WSJ

Print Friendly, PDF & Email

Spread the wealth.

twitter
facebook
linkedin

What's been said:

Discussions found on the web:

Posted Under

Uncategorized

Previous Post

Interpreting Deviations from Okun’s Law

Next Post

Spec-Tech Crash Is a Good Thing

  • About Barry Ritholtz

      Barry L. Ritholtz is co-founder, chairman, and chief investment officer of Ritholtz Wealth Management LLC. Launched in...

    Read More

  • Say Hello

  • Disclosures
    Privacy Policy
    Terms and Conditions

  • Masters In Business

    Listen To My Podcast on iTunes

  • Bloomberg Opinion

    See My Bloomberg Opinion Posts

  • The Washington Post

    Read My Washington Posts Columns

  • Quote of the Day

    It is the working man who is the happy man. It is the idle man who is the miserable man.
    Benjamin Franklin

  • Categories

  • Bailout Nation

    img-book

    How Greed and Easy Money Corrupted Wall Street and Shook the World Economy
    Learn More...

    Amazon.com

  • Archives

    • About The Big Picture
    • FAQ
    • What the Press Says
    • Legal Disclosures
    • Advertising Disclosures

  • Newsletter

    Get subscriber-only insights and news delivered by Barry daily.

© 2023 The Big Picture

Sign Up for My Newsletter

Get subscriber-only insights and news delivered by Barry every two weeks.